Physician profile
Todd B Francis
NPI 1265607139
$19,158.27
in general payments reported to CMS, 2019-2025
15 companies · $8,215 in 2025
The $8,215 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,106 · 2020: $361 · 2021: $4,515 · 2022: $111 · 2024: $1,851 · 2025: $8,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,450 · Travel and Lodging: $2,784 · Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,450.00 |
| Travel and Lodging | $2,783.52 |
| Food and Beverage | $831.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $8,620.24 | 2024-2025 | Spine-None, Vital, Mobi-C Plug & Fit US |
| Nuvasive, INC. | $7,446.76 | 2019-2021 | |
| Si-Bone, INC. | $1,077.03 | 2019 | |
| Zimvie INC. | $723.20 | 2024 | |
| Globus Medical, INC. | $573.34 | 2024 | Excelsiusgps Robotic Navigation System |
| Nevro Corp. | $227.01 | 2019-2020 | |
| Medtronic USA, INC. | $207.86 | 2019-2020 | |
| Boston Scientific Corporation | $148.68 | 2025 | Intracept |
| Spineology INC. | $30.50 | 2022 | |
| Stryker Corporation | $23.60 | 2022 | |
| Spinal Simplicity, LLC | $22.80 | 2021 | |
| Depuy Synthes Sales INC. | $15.24 | 2022 | |
| Seaspine Orthopedics Corporation | $15.10 | 2022 | |
| Orthofix Medical, INC. | $14.67 | 2022 | |
| Theragen, INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.